Conferences and Events > Previous Conferences and Events > 2022 Conferences and Events > British HIV Association Spring Conference 2022 >

British HIV Association Spring Conference 2022 - Presentations

Date: 20–22 April 2022

Venue: Manchester Central, Manchester, UK


Wednesday 20th April 2022

Welcome & Introduction by the Chair of BHIVA
Dr Laura Waters, Mortimer Market Centre, London, UK

Plenary: update on opportunistic infections
Dr Angela Bailey, Buckinghamshire Healthcare NHS Trust, UK

ART update: strategies & drugs
Dr Laura Waters, Mortimer Market Centre, London, UK

COVID-19 Update


The Challenge of managing postacute COVID-19

Dr Swapna Mandal Royal Free London NHS Foundation Trust, UK

Covid treatment update
Dr Alison Uriel, Manchester University Foundation Trust, UK

COVID-19 immunity and vaccine efficacy in people living with HIV
Dr Dimitra Peppa, University College London, UK

Oral Session 1

O1 Self start HOME HIV Post exposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy: A RCT
Dr Julie Fox, Guys and St Thomas’ NHS Trust, UK

O2 HIV testing outcomes amongst pre-exposure HIV prophylaxis (PrEP) users accessing a regional online sexual health service (e-SHS)
Molly Dickinson, Chelsea and Westminster Hospital, London, UK

O3 Experiences of PrEP stigma and discrimination in healthcare settings in the UK among a community sample of PrEP users
Amber Newbigging-Lister, UK Health Security Agency, UK

O4 Driving towards zero, bringing HIV testing and prevention to migrant communities across London
Poppy Vernon, METRO Charity, UK

O5 Estimating the number of people living with transmissible HIV in England in 2020
Dr Veronique Martin, UK Health Security Agency, UK

Parallel workshops

Achieving the HIV Action Plan Goals: Building closer ties between HIV Prevention England and clinicians
Alex Sparrowhawk, Terrence Higgins Trust, UK
Professor Matt Phillips, North Cumbria Integrated Care NHS Foundation Trust, UK
Anne Glew, The Brunswick Centre
Anthony Harrison-West, Renaissance UK

SWIFT workshop: WONDER, Women and Bones
Professor Yvonne Gilleece, University Hospitals Sussex NHS Foundation Trust, UK
Ms Fungai Murau, Independent Consultant, UK
Hajra Okhai, University College London, UK

Oral Session 2

O6 Mortality among people with HIV in the UK in 2020: findings from the National HIV Mortality Review
Dr Sara Croxford, UK Health Security Agency, UK

O7 Improving short-term mortality of people living with HIV admitted to the Intensive Care Unit: A 20-year study (2000-2019)
Dr Tanmay Kanitkar, Royal Free Hospital, UK

O8 Addressing a significant health inequality: a project to re-engage patients lost to HIV follow up
Dr Kate Childs, King’s College Hospital NHS Foundation Trust, UK

O9 Investigating the pregnancy and post-partum health experiences of women living with HIV: The NESTOR study
Rebecca Cooper, Sheffield Medical School, UK

O10 Pregnancy characteristics and outcomes of women with vertically-acquired HIV in the UK
Helen Peters, UCL Great Ormond Street Institute of Child Health, UK

M184V: does it matter?
Professor Chloe Orkin, Queen Mary University of London, UK

Pregnancy & reproductive health updates/conundrums


Pregnancy/breastfeeding update

Dr Laura Byrne, St George’s University Hospitals NHS Foundation Trust, UK

Contraceptive Choices - Transgender Patient
Dr Louise Melvin, Sandyford Sexual Health Service, UK

Post-reproductive health in women living with HIV
Dr Shema Tariq, University College London/Mortimer Market Centre, UK

Panel Discussion Members
Professor Yvonne Gilleece, University Hospitals Sussex NHS Foundation Trust, UK & Bakita Kasadha, University of Oxford, UK


Thursday 21st April 2022

Malignancy update
Professor Stéphane de Wit, Saint-Pierre University Hospital, Belgium

What is new about hepatitis B? From novel biomarkers to innovative cure strategies
Professor Anna Maria Geretti, University of Rome Tor Vergata, Rome, Italy & King’s College London, London, UK

AUDIT Session


A national audit of the management of HIV-2 in adults in the UK

Dr Maya Tickell-Painter, Manchester Foundation Trust, UK

Multi-drug resistant HIV 2: let’s think outside the box
Dr Athavan Umaipalan, Barking, Havering & Redbridge NHS Trust, UK

European perspective on BHIVA Audit/Standards
Professor. Dr Jürgen Rockstroh, University Hospital Bonn, Germany

Audit reflections
Dr Hilary Curtis, Clinical Audit Co-ordinator BHIVA, UK

Oral Session 3

O11 Inflammatory biomarker clusters based on protein biomarkers measured in people living with and without HIV
Nicholas Bakewell, University College London, UK

O12 Exploring frailty and frailty screening for older people living with HIV
Natalie St Clair-Sullivan, Brighton and Sussex Medical School, UK

O13 Anticholinergic medications associated with falls and frailty in people with HIV
Dr Jessica Doctor, Guy’s and St Thomas’ Hospital, UK

O14 Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis
Dr Georgina Keogh, Chelsea & Westminster Hospital, UK

O15 Closing the circle: use of a data visualisation application (Qlik Sense®) to support quality improvement in HIV services
Dr Michael Butler, Imperial College Healthcare NHS Trust, UK

Fast-Track Cities update

Fast-Track Cities as a leveraging tool for local innovations and an instrument of international solidarity
Mr Bertrand Audoin, International Association of Providers of AIDS Care

Fast-Track Cities: A Greater Manchester perspective, the importance of collaborative leadership
Mr Rob Cookson, LGBT Foundation

Testing the way to join elimination of HIV and Hepatitis C
Dr F Javier Vilar, North Manchester General Hospital, Manchester Foundation Trust

HIV Medicine workshop: Improving your publication success rate


Professor Caroline Sabin, University College London, UK
Dr Laura Waters, Mortimer Marker Centre, London, UK
Professor Jürgen Rockstroh, University Hospital Bonn, Germany

Oral Session 4

O16 Incidence of Metabolic Complications Among Treatment-naïve Adults Living With HIV-1 Randomised to B/F/TAF, DTG/ABC/3TC or DTG + F/TAF After 3 Years
Professor Chloe Orkin, Queen Mary University of London, UK

O17 Safety profile of cabotegravir + rilpivirine during oral lead-in and through long-acting therapy: pooled analysis of the phase 3 FLAIR, ATLAS, and ATLAS-2M studies
Dr Paul D. Benn, ViiV Healthcare, UK

O18 The acceptability of offering rapid antiretroviral therapy to people living with HIV in East London: A qualitative study
Dr Rageshri Dhairyawan, Barts Health NHS Trust, UK

O19 HIV and mental health: improving generic NHS talking therapy services for people living with HIV in England
Calum Douglas, National AIDS Trust, UK

O20 Rebuilding the missing link to the Fourth 90: Addressing the mental health needs of an urban population of people living with HIV in a Greater London clinic
Bonaventure Carl De Souza, Croydon University Hospital, UK

HIV and mortality in the current climate


SpR case

Dr Erica Pool, Mortimer Market Centre / UCL, UK

Posthumous disclosure
Professor Matt Phillips, North Cumbria Integrated Care NHS Foundation Trust, UK

Death certification – facts and practicalities
Professor Sebastian Lucas, Guy’s & St Thomas’ NHS Foundation Trust, UK

Defining and monitoring preventable HIV-related mortality
Dr Sara Croxford, Principal Scientist, UK and Health Security Agency, UK


Friday 22nd April 2022

Themed Poster session
Posters TP01-TP08

Chronic Pain Session


Psychosocial factors associated with chronic pain and its management in people living with HIV
Dr Whitney Scott, King’s College London/Guy’s & St Thomas’ NHS Foundation Trust, UK

Clinical Management of chronic pain
Dr Harriet Kemp, Imperial College Healthcare NHS Trust, UK

Best poster session

Science Session (Brian Gazzard Lecture)


HIV pathogenesis & the role of the microbiome

Dr Roger Paredes, Germans Trias i Pujol University Hospital/Irsi Caixa, Spain

Inflammation & the role of ART
Dr Jose Arribas, La Paz University Hospital, Spain

Parallel workshops

Adverse Childhood Experiences and their impact on Adult HIV Care
Dr Caroline Foster, Imperial College Healthcare NHS Trust, UK
Dr Caroline Johnson, Imperial College Healthcare NHS Trust, UK & young adult speakers from CHIVA providing lived experiences

Living Well with HIV – personalising multiple long term condition management


Jim Fielder, Terrence Higgins Trust, UK
Dr Daniella Chilton, Guy’s and St Thomas’ NHS Foundation Trust, UK
Dr Howell Jones, Royal Free London NHS Foundation Trust, UK
Dr Fiona Marra, NHS Greater Glasgow and Clyde, and University of Liverpool, UK

Guidelines/Position Statements


ART Guidelines

Dr John Walsh, Imperial College Healthcare NHS Trust, UK

HIV, disclosure & the law
Professor Matt Phillips, North Cumbria Integrated Care NHS Foundation Trust, UK

Clinico-pathological case presentations

Awards and closing remarks
Dr Laura Waters, Mortimer Market Centre, London, UK